Form 4: Vera Therapeutics SVP Joseph R. Young Reports Stock Sales
SEC Form 4
Joseph R. Young, SVP of Finance and Chief Accounting Officer at Vera Therapeutics, reports the sale of company stock and the exercise of stock options.
Summary
- Joseph R. Young, SVP of Finance, Chief Accounting Officer of Vera Therapeutics, filed a Form 4 detailing changes in beneficial ownership.
- On May 15, 2024, Young exercised stock options to acquire 8,221 shares of Class A Common Stock at a price of $3.9396 and sold the same amount at a weighted average price of $42.17 and $42.68.
- On May 16, 2024, Young exercised stock options to acquire 18,151 shares of Class A Common Stock at a price of $7.87 and sold the same amount at a weighted average price of $42.219.
- On May 16, 2024, Young exercised stock options to acquire 2,500 shares of Class A Common Stock at a price of $7.87 and sold the same amount at a weighted average price of $43.029.
- Following these transactions, Young directly owns 51,206 shares of Class A Common Stock.
- Young also holds options to purchase 69,349 shares of Class A Common Stock at $7.87 and 58,589 shares at $3.9396.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing (Form 4) detailing stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the insider's trading activity.
Industry Context
Form 4 filings are a routine part of the regulatory landscape, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 03/09/2022 | 1/4 of the shares subject to the $3.9396 stock option vested. |
| 02/15/2023 | 1/48 of the total $7.87 stock option vests and becomes exercisable monthly on the same day of each month following February 15, 2023, subject to continuous service of the Reporting Person on each vesting date. |
| 04/13/2031 | Expiration date of stock options with exercise price of $3.9396. |
| 02/14/2033 | Expiration date of stock options with exercise price of $7.87. |
| 05/15/2024 | Earliest transaction date; exercise of stock options and sale of shares. |
| 05/16/2024 | Exercise of stock options and sale of shares. |
| 05/17/2024 | Date of signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.